Letter to the EditorRe: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.
Cited by (0)
© 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.